Juan Francisco
Navarro González
Investigador Externo
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (19)
2024
-
Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care
Nefrologia , Vol. 44, Núm. 2, pp. 241-250
2022
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
2021
-
Optimizing the timing of nephrology referral for patients with diabetic kidney disease
Clinical Kidney Journal, Vol. 14, Núm. 1, pp. 5-8
2020
-
Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease
Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024
-
GLP-1 receptor agonists and diabetic kidney disease: A call of attention to nephrologists
Journal of Clinical Medicine, Vol. 9, Núm. 4
-
SGLT2 inhibitors for non-diabetic kidney disease: Drugs to treat CKD that also improve glycaemia
Clinical Kidney Journal, Vol. 13, Núm. 5, pp. 728-733
2019
-
Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort
Frontiers in Genetics, Vol. 10, Núm. FEB
-
Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: What was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?
Clinical Kidney Journal, Vol. 12, Núm. 3, pp. 313-321
-
Will the new hypoglycaemic agents be effective on renal and cardiovascular protection in diabetes and renal diabetic disease?
Nefrologia, Vol. 39, Núm. 1, pp. 3-10
2018
-
Effects of pentoxifylline on soluble klotho concentrations and renal tubular cell expression in diabetic kidney disease
Diabetes Care, Vol. 41, Núm. 8, pp. 1817-1820
2017
-
Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study
Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520
2015
-
Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease
Nephrology Dialysis Transplantation, Vol. 30, Núm. 7, pp. 1176-1185
-
Nephroprotection by hypoglycemic agents: Do we have supporting data?
Journal of Clinical Medicine, Vol. 4, Núm. 10, pp. 1866-1889
2014
-
Diabetic kidney disease: From physiology to therapeutics
Journal of Physiology, Vol. 592, Núm. 18, pp. 3997-4012
2013
-
Activación de los receptores de vitamina Den la optimización del hiperparatiroidismo secundario en diálisis
Nefrologia, Vol. 33, Núm. 4, pp. 571-584
2012
-
A propósito de las discrepancias entre documentos de consenso, guías de práctica clínica y normativa legal en el tratamiento de la diabetes tipo 2
Nefrologia
-
About the discrepancies between consensus documents, clinical practice guidelines, and legal regulations in the treatment of type 2 diabetes
Nefrologia
-
Discrepancies between the summary of characteristics and the recommended use of metformin in the treatment of type 2 diabetes mellitus patients
Nefrologia